// company-profile

Rein Therapeutics, Inc.

RNTX
ExchangeNasdaqSectorPharmaceutical PreparationsFilings35Insiders12
// api This Rein Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares (net $29K). Buying was led by VON RICKENBACH JOSEF H.

// 90-day insight

Over the last 90 days, Rein Therapeutics, Inc. insiders bought $75K across 6 transactions with no open-market sales.

  • Most active insider: VON RICKENBACH JOSEF H with 4 transactions totaling $50K.
  • Largest single purchase: $25K by WINDSOR JAMES BRIAN on Apr 30, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Rein Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$14.6M
QoQ change
+17.5%
Reporting period
2026-03-31
#1
Voss Capital, LP
CIK 1730145
$5.7M
4.4M shares
#2
BIOS Capital Management, LP
CIK 1813845
$2.3M
1.8M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$1.3M
999K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 27, 2026VON RICKENBACH JOSEF HRNTX
Purchase
4,500$1.07$5K
May 26, 2026VON RICKENBACH JOSEF HRNTX
Purchase
23,190$1.06$24K
May 22, 2026VON RICKENBACH JOSEF HRNTX
Purchase
15,950$1.05$17K
May 21, 2026VON RICKENBACH JOSEF HRNTX
Purchase
3,420$1.04$4K
May 8, 2026WINDSOR JAMES BRIANRNTX
Award
150,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.